Get startedLog in
    Picture of Matinas BioPharma Holdings logo

    MTNB — Matinas BioPharma Holdings News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Matinas Biopharma Announces Issuance Of U.S. Patent Protecting Mat2203 To Treat Or Prevent Cryptococcus Infections

    Picture of Matinas BioPharma Holdings logoMatinas BioPharma Holdings
    16/08/2021 12:22
    Aug 16 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA ANNOUNCES ISSUANCE OF U.S. PATENT
PROTECTING
MAT2203 TO TREAT OR PREVENT CRYPTOCOCCUS INFECTIONS

Source text for Eikon:  ID:nGNX5CGqmV 
Further company coverage:  MTNB.A 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Matinas BioPharma Holdings

    See all news